Stories
Motilal Oswal Initiates 'Buy' on Aster DM Quality Care, Sees 46% Upside to ₹910 Target
C
CNBC Awaaz•28-09-2026, 17:46
Motilal Oswal Initiates 'Buy' on Aster DM Quality Care, Sees 46% Upside to ₹910 Target
- •Motilal Oswal initiated coverage on Aster DM Quality Care with a 'Buy' rating and a target price of ₹910, indicating a potential upside of 20%.
- •The merger of Aster DM Healthcare and Quality Care India (QCIL) has made it one of the largest hospital networks in India, with 39 hospitals and 10,600 operational beds.
- •The company aims to increase its bed capacity to over 15,000 by fiscal year 2030 through a balanced approach.
- •In a bull case scenario, the stock is projected to see an upside of approximately 46%, driven by successful merger integration and operational savings.
- •Key risks include delays in QCIL integration, expansion delays, and regulatory changes impacting profitability.
Key Questions Answered
Motilal Oswal initiated coverage on Aster DM Quality Care with a 'Buy' rating and set a base case target price of ₹910 per share.
The merger of Aster DM Healthcare and Quality Care India resulted in a network of 39 hospitals and approximately 10,600 operational beds across 28 cities.
The company aims to increase its operational bed capacity to over 15,000 by fiscal year 2030 using brownfield, greenfield, and asset-light models.
